We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.26B
AUM Growth
-$105M
Cap. Flow
-$52.6M
Cap. Flow %
-4.16%
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34

Top Buys

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$51.8M
2
BEKE icon
KE Holdings
BEKE
+$31M
3
TSM icon
TSMC
TSM
+$10.9M
4
BZ icon
Kanzhun
BZ
+$6.35M
5
IQ icon
iQIYI
IQ
+$4.37M

Top Sells

Rank Stock Value
1
TME icon
Tencent Music
TME
+$39.2M
2
TCOM icon
Trip.com Group
TCOM
+$19.3M
3
MRVL icon
Marvell Technology
MRVL
+$12M
4
WB icon
Weibo
WB
+$7.99M
5
JOYY
JOYY Inc
JOYY
+$7.61M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.28%
2 Technology 32.43%
3 Communication Services 9.6%
4 Healthcare 8.37%
5 Real Estate 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWST icon
126
Twist Bioscience
TWST
$5.62B
$455K 0.04%
22,246
-2,228
-9% -$33.4K
APLS
127
DELISTED
Apellis Pharmaceuticals
APLS
$452K 0.04%
4,963
-1,244
-20% -$107K
ARWR icon
128
Arrowhead Research
ARWR
$12.1B
$451K 0.04%
12,646
-2,033
-14% -$70.1K
IONS icon
129
Ionis Pharmaceuticals
IONS
$9.35B
$451K 0.04%
10,988
-384
-3% -$14.8K
NBIX icon
130
Neurocrine Biosciences
NBIX
$17.7B
$451K 0.04%
4,783
+752
+19% +$73.5K
CTAS icon
131
Cintas
CTAS
$82.4B
$450K 0.04%
3,620
-648
-15% -$76K
ALKS icon
132
Alkermes
ALKS
$8.82B
$449K 0.04%
14,348
-165
-1% -$5K
NTRA icon
133
Natera
NTRA
$37.5B
$449K 0.04%
9,232
+2,097
+29% +$107K
ALNY icon
134
Alnylam Pharmaceuticals
ALNY
$36.3B
$445K 0.04%
2,341
+226
+11% +$44.8K
EXEL icon
135
Exelixis
EXEL
$13.9B
$445K 0.04%
23,263
+110
+0.5% +$2.12K
MELI icon
136
Mercado Libre
MELI
$91.3B
$444K 0.04%
375
-73
-16% -$91.8K
NVAX icon
137
Novavax
NVAX
$1.23B
$444K 0.04%
59,792
+561
+0.9% +$4.41K
BEAM icon
138
Beam Therapeutics
BEAM
$2.58B
$443K 0.04%
13,867
+1,851
+15% +$60.1K
PCVX icon
139
Vaxcyte
PCVX
$7.89B
$441K 0.03%
8,834
-1,378
-13% -$65.3K
PRTA icon
140
Prothena Corp
PRTA
$458M
$439K 0.03%
6,427
-1,622
-20% -$105K
FOLD
141
DELISTED
Amicus Therapeutics
FOLD
$438K 0.03%
34,867
+1,109
+3% +$13.2K
GEHC icon
142
GE HealthCare
GEHC
$27.6B
$436K 0.03%
+5,361
New +$428K
PFE icon
143
Pfizer
PFE
$140B
$434K 0.03%
11,829
-1,075
-8% -$41.8K
ACAD icon
144
Acadia Pharmaceuticals
ACAD
$4.25B
$433K 0.03%
18,068
-799
-4% -$17.8K
TEL icon
145
TE Connectivity
TEL
$58.8B
$432K 0.03%
3,079
-337
-10% -$42.6K
UTHR icon
146
United Therapeutics
UTHR
$26.3B
$432K 0.03%
1,955
+266
+16% +$58.9K
TMO icon
147
Thermo Fisher Scientific
TMO
$211B
$431K 0.03%
826
-83
-9% -$44.8K
LVS icon
148
Las Vegas Sands
LVS
$30.5B
$430K 0.03%
7,406
-52
-0.7% -$3.08K
KDNY
149
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$430K 0.03%
11,196
+907
+9% +$23.3K
KRTX
150
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$426K 0.03%
1,963
-194
-9% -$41.6K
4 5
6
7 8

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q2 2023 Portfolio in Review

As of Q2 2023, E Fund Management held 343 positions worth $1.26B, down 7.7% from $1.37B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management withdrew a net $52.6M in Q2 2023, closing 34 positions and reducing 233 holdings. Its most notable exit was Trip.com Group, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 36% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Datadog worth $881K.

  • E Fund Management's largest Q2 2023 buy was Datadog: 8,960 shares worth $881K.
  • E Fund Management added most to Pinduoduo in Q2 2023, an estimated $51.8M increase.
  • E Fund Management's biggest Q2 2023 reduction was Tencent Music, cutting an estimated $39.2M.
  • E Fund Management fully exited Trip.com Group in Q2 2023, selling an estimated $19.3M.
  • E Fund Management's ten largest holdings make up 61% of its $1.26B portfolio in Q2 2023.
  • E Fund Management opened 11 new positions and closed 34 in Q2 2023.
  • E Fund Management's portfolio value fell 7.7% quarter-over-quarter to $1.26B.

Based on E Fund Management's 13F filing for Q2 2023, filed 11 Aug 2023.